Latest South Korean Market News

X2M Connect has unveiled a new AI-enabled bidirectional streetlight controller in South Korea, expanding its smart city platform and tapping into a $225 million annual market.

Osteopore Limited reported a 30% year-on-year revenue increase in Q4 CY25, overcoming a slowdown in South Korea, and secured a strategic five-year partnership with DKSH Malaysia to expand its dental product reach.

Green Critical Minerals has signed a landmark MoU with South Korea’s Komex Carbon Corporation to co-develop and commercialize Very High Density (VHD) carbon products, marking GCM’s first international commercial agreement and a key step toward revenue generation in 2026.

Green Critical Minerals advances its Very High Density graphite technology with strong thermal performance validation, production scale-up, and strategic moves into global markets including a planned US listing.

Botanix Pharmaceuticals’ ECCLOCK® gel, a treatment for excessive sweating, has secured regulatory approval in South Korea, paving the way for a commercial launch in early 2026.

X2M Connect Limited reported a $12.1 million loss for FY25, driven by a 43% revenue drop amid a softer South Korean market and the strategic exit from China. Despite cost cuts and improved margins, the company’s adjusted EBITDA loss widened, prompting a $5.4 million capital raise to shore up its balance sheet.

X2M Connect Limited has secured over $5.5 million in new South Korean contracts for remote water metering, signaling strong momentum heading into FY26. The company’s expanding customer base and addressable market highlight its growing influence in the Asia-Pacific IoT sector.

X2M Connect reports a challenging quarter with a 64% revenue drop due to exiting low-margin hardware sales but boosts gross margin and expands its footprint with new contracts in the Middle East and South Korea alongside launching an AI platform for renewables.

Osteopore Limited reported a robust 26% quarter-on-quarter revenue increase in Q1 CY25, bolstered by a key Singapore subsidy listing and a strategic pivot away from its dental project to sharpen commercial focus.